{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:22:38Z","timestamp":1697502158195},"reference-count":34,"publisher":"Baishideng Publishing Group Inc.","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2006]]},"DOI":"10.3748\/wjg.v12.i20.3283","type":"journal-article","created":{"date-parts":[[2016,3,16]],"date-time":"2016-03-16T07:10:54Z","timestamp":1458112254000},"page":"3283","source":"Crossref","is-referenced-by-count":5,"title":["Investigation of HER-2 codon 655 single nucleotide polymorphism frequency and c-ErbB-2 protein expression alterations in gastric cancer patients"],"prefix":"10.3748","volume":"12","author":[{"given":"N Lale","family":"Satiroglu-Tufan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","unstructured":"Mansfield PF, Yao JC, Crane CH. Holland-Frei Cancer Medicine 6 Hamilton: BC Decker Inc; 2003;1515-1542."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/scientificamerican0996-62"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2003.06.002"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1126\/science.2999974"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1126\/science.3012781"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/319226a0"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)00114-8"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203972"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11476"},{"key":"ref10","unstructured":"Lee EY, Cibull ML, Strodel WE, Haley JV. Expression of HER-2\/neu oncoprotein and epidermal growth factor receptor and prognosis in gastric carcinoma. Arch Pathol Lab Med 1994;118:235-239."},{"key":"ref11","unstructured":"Slesak B, Harlozinska A, Porebska I, Bojarowski T, Lapinska J, Rzeszutko M, Wojnar A. Expression of epidermal growth factor receptor family proteins (EGFR, c-erbB-2 and c-erbB-3) in gastric cancer and chronic gastritis. Anticancer Res 1998;18:2727-2732."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/19.19.5452-a"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.10129"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Ougolkov A, Yamashita K, Bilim V, Takahashi Y, Mai M, Minamoto T. Abnormal expression of E-cadherin, beta-catenin, and c-erbB-2 in advanced gastric cancer: its association with liver metastasis. Int J Colorectal Dis 2003;18:160-166.","DOI":"10.1007\/s00384-002-0427-2"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0215(200002)9999:9999&lt;::AID-IJC1061&gt;3.0.CO;2-Y"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Nakajima M, Sawada H, Yamada Y, Watanabe A, Tatsumi M, Yamashita J, Matsuda M, Sakaguchi T, Hirao T, Nakano H. The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas. Cancer 1999;85:1894-1902.","DOI":"10.1002\/(SICI)1097-0142(19990501)85:9<1894::AID-CNCR3>3.0.CO;2-J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19931001)72:7&lt;2083::AID-CNCR2820720705&gt;3.0.CO;2-1"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"G&uuml;rel S, Dolar E, Yerci O, Samli B, Ozt&uuml;rk H, Nak SG, G&uuml;lten M, Memik F. The relationship between c-erbB-2 oncogene expression and clinicopathological factors in gastric cancer. J Int Med Res 1999;27:74-78.","DOI":"10.1177\/030006059902700203"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910530115"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.5.412"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2003.12.005"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2004.04.007"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1023\/A:1024068525763"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s100380200019"},{"key":"ref25","unstructured":"McKean-Cowdin R, Kolonel LN, Press MF, Pike MC, Henderson BE. Germ-line HER-2 variant and breast cancer risk by stage of disease. Cancer Res 2001;61:8393-8394."},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Stark A, Hulka BS, Joens S, Novotny D, Thor AD, Wold LE, Schell MJ, Melton LJ 3rd, Liu ET, Conway K. HER-2\/neu amplification in benign breast disease and the risk of subsequent breast cancer. J Clin Oncol 2000;18:267-274.","DOI":"10.1200\/JCO.2000.18.2.267"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1159\/000011898"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3109\/07357900009023056"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.11450"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1126\/science.2470152"},{"key":"ref31","unstructured":"Kameda T, Yasui W, Yoshida K, Tsujino T, Nakayama H, Ito M, Ito H, Tahara E. Expression of ERBB2 in human gastric carcinomas: relationship between p185ERBB2 expression and the gene amplification. Cancer Res 1990;50:8002-8009."},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(97)10157-5"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.24.1991"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1053\/paor.1999.0171"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T06:06:20Z","timestamp":1600322780000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v12\/i20\/3283.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006]]},"references-count":34,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.v12.i20.3283","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2006]]}}}